A better understanding of pharmacological activities and uses of phytochemicals of Lycopodium clavatum: A review

Lycopodium clavatum commonly known as club moss belongs to family Lycopodiaceae is a plant of great interest and is used in combating a wide variety of diseases in European and Asian countries. Crude extracts from various parts of the plant contain quinolizidine alkaloids. Several workers have reported various alkaloids derived from this plant and their therapeutic potentials, however, some reports are available on toxicity studies of alkaloids of this plant. In such a scenario, there is a need for better understanding of its ameliorating potential and its toxic actions. This review summarizes scientific findings and suggests areas where further research is needed.

[1]  William F. Boericke.  New manual of homoeopathic materia medica and repertory , 2013 .

[2]  K. P. Singh,et al.  Preliminary study to evaluate analgesic and behavioural effects of Lycopodium clavatum in experimental animals , 2013 .

[3]  Avijit Paul,et al.  The potentized homeopathic drug, Lycopodium clavatum (5C and 15C) has anti-cancer effect on hela cells in vitro. , 2013, Journal of acupuncture and meridian studies.

[4]  K. Bishayee,et al.  Lycopodine triggers apoptosis by modulating 5-lipoxygenase, and depolarizing mitochondrial membrane potential in androgen sensitive and refractory prostate cancer cells without modulating p53 activity: signaling cascade and drug-DNA interaction. , 2013, European journal of pharmacology.

[5]  A. Khuda-Bukhsh,et al.  Apigenin-induced apoptosis in A375 and A549 cells through selective action and dysfunction of mitochondria , 2012, Experimental biology and medicine.

[6]  J. Moreira,et al.  Investigation of the in vitro and ex vivo acetylcholinesterase and antioxidant activities of traditionally used Lycopodium species from South America on alkaloid extracts. , 2012, Journal of ethnopharmacology.

[7]  S. Dutta,et al.  Lycopodine from Lycopodium clavatum extract inhibits proliferation of HeLa cells through induction of apoptosis via caspase-3 activation. , 2010, European journal of pharmacology.

[8]  M. Mandal,et al.  An ethnobotanical study of traditional anti-inflammatory plants used by the Lohit community of Arunachal Pradesh, India. , 2009, Journal of ethnopharmacology.

[9]  G. Mackenzie,et al.  Sporopollenin. A novel, naturally occurring support for solid phase peptide synthesis. , 2009, International journal of peptide and protein research.

[10]  S. Pathak,et al.  Protective potentials of a potentized homeopathic drug, Lycopodium-30, in ameliorating azo dye induced hepatocarcinogenesis in mice , 2006, Molecular and Cellular Biochemistry.

[11]  J. Rollinger,et al.  New insights into the acetylcholinesterase inhibitory activity of Lycopodium clavatum. , 2005, Planta medica.

[12]  H. Kikuzaki,et al.  Antioxidant properties of ferulic acid and its related compounds. , 2002, Journal of agricultural and food chemistry.

[13]  P. Gerard,et al.  Insecticidal activity of huperzine A from the New Zealand clubmoss, Lycopodium varium. , 2002, Journal of Agricultural and Food Chemistry.

[14]  H. Zhang,et al.  Huperzine B, a novel acetylcholinesterase inhibitor, attenuates hydrogen peroxide induced injury in PC12 cells , 2000, Neuroscience Letters.

[15]  Rui Wang,et al.  Protective effects of huperzine A on β-amyloid25–35 induced oxidative injury in rat pheochromocytoma cells , 2000, Neuroscience Letters.

[16]  Jian Yang,et al.  Huperzine A protects rat pheochromocytoma cells against hydrogen peroxide-induced injury , 1999, Neuroscience Letters.

[17]  S. Kadota,et al.  Screening of crude drug extracts for prolyl endopeptidase inhibitory activity. , 1999, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[18]  E. Graf,et al.  Antioxidant potential of ferulic acid. , 1992, Free radical biology & medicine.

[19]  D. Taşdemir,et al.  Antiprotozoal activity and cytotoxicity of Lycopodium clavatum and Lycopodium complanatum subsp. chamaecyparissus extracts , 2013 .

[20]  W. Staines,et al.  Cree antidiabetic plant extracts display mechanism-based inactivation of CYP3A4. , 2011, Canadian journal of physiology and pharmacology.

[21]  I. Orhan,et al.  Alpha-onocerin: an acetylcholinesterase inhibitor from Lycopodium clavatum. , 2003, Planta Medica.

[22]  G. W. Jürgensen,et al.  Lycopodium spores in transrectal ultrasound-guided core biopsies of the prostate. , 1998, Scandinavian journal of urology and nephrology.

[23]  W. Ayer.  The lycopodium alkaloids. , 1991, Natural product reports.